IWC
PTCT icon

Integrated Wealth Concepts’s PTC Therapeutics PTCT Stock Holding History

Integrated Wealth Concepts’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193K Buy
+2,362
New +$171K ﹤0.01% 2359

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Integrated Wealth Concepts's PTCT Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 2,362 shares worth $193K. The stake represents ﹤0.01% of the portfolio and ranks #2359 among its holdings.

382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Integrated Wealth Concepts held 2,362 shares of PTC Therapeutics worth $193K as of Q2 2026.
  • PTC Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #2359 holding.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.